Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome
Alexandra Moore, Amanda K. Burrows, Richard Malík, Rudayna M. Ghubash, Robert D. Last, Benjamin Remaj
Abstract
Toxoplasma gondii is a ubiquitous protozoan, for which felids are the definitive host. Immunocompromised individuals are susceptible to recrudescent toxoplasmosis. This case describes a 6-year-old, feline immunodeficiency virus-positive domestic short hair cat with feline atopic skin syndrome that developed fatal toxoplasmosis after treatment with oclacitinib for five months.
Topics & Concepts
Feline immunodeficiency virusToxoplasmosisToxoplasma gondiiMedicineVirologyCATSProtozoan parasiteHuman immunodeficiency virus (HIV)ImmunologyLentivirusViral diseaseAntibodyInternal medicineParasite hostingWorld Wide WebComputer scienceToxoplasma gondii Research StudiesHerpesvirus Infections and TreatmentsRabies epidemiology and control